From 2007 to 2011, the government estimates the number of emergency room visits involving the neon-labeled beverages shot up from about 10,000 to more than 20,000.

New research from Harvard University's School of Public Health and the non-profit Legacy Foundation found that graphic warnings on cigarette packets may help smokers who are trying to quit.

The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs.

U.S. regulators approved 39 new drugs in 2012, the most in 16 years.

Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.

This is the first time the FDA used the authority granted under a 2011 food safety law.

Tobacco companies have introduced almost no new cigarettes or smokeless tobacco products in the U.S. in more than 18 months.

The FDA expanded approval of J&J's prostate cancer pill Zytiga for men with an earlier stage of prostate cancer.

The federal government may release genetically modified mosquitoes to reduce risk of dengue fever in Key West.

A partnership to speed the development and review of new device products has been formed.